Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Sarepta Therapeutics Inc (SRPT)

NASDAQ
Currency in USD
Disclaimer
135.04
+1.38(+1.03%)
Closed
After Hours
133.35-1.69(-1.25%)

SRPT Comments

will definetly get over 120$ very soon
I change my mind. I'm in
50
Get to 100!!
*******
more bad news on the way!
storm will hit Florida again.
only bad news I know about SRPT is will hit back 150$ soon, instead of 160$.
☝️🤡
120 GOGOGOGO
Buy Buy BuyThis was a strong overreaction to the delays. They still have what, 40 othrr therapies in the works?
Bat ther'is a legale action in that Moment. .Whot about?
started a small position around $84. Think it`s a screaming buy at RSI around 16. Totally oversold !
wait 75
25percent up on monday?
no
2.5 percent up
el barco se hunde, hay que salir
Aún queda recorrido hacia abajo. Buena ocasión para entrar en un rato.
analyst set target price at 166.00
When you will lose your money analyst wont be there for you
their therapy failed. good luck to those who wants to buy in
time to buy?
Probably notWait until next week
Watch out,,,
what happen?
Hajrá SZARepta! 💸💸💸
Bought the dip @86.60.  Hope it is just a dip and not tragedy.
actually it is a tragedy because its gene therapy failed to be effective in trials, thats why it drops down by 50%. watch out...
Who ever had otm puts just made mad bank
Target price 176, 190, 260
will srpt go higher since its drug approval or will it fill the gap
I´ll buy it at 61-63$ range. Looking nice for october!
strong sell
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.